Lanean...
A clinically relevant population of leukemic CD34(+)CD38(−) cells in acute myeloid leukemia
Relapse of acute myeloid leukemia (AML) is thought to reflect the failure of current therapies to adequately target leukemia stem cells (LSCs), the rare, resistant cells presumed responsible for maintenance of the leukemia and typically enriched in the CD34(+)CD38(−) cell population. Despite the con...
Gorde:
| Egile Nagusiak: | , , , , , , , , , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
American Society of Hematology
2012
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3325044/ https://ncbi.nlm.nih.gov/pubmed/22262762 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2011-06-364182 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|